Akt1 induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells

Cancer Research

Volumn 61, Issue 20, 2001, Pages 7647-7653

  Park, Bae Keun ^a   Zeng, Xiao ^a   Glazer, Robert I ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; PROTEASOME; PROTEIN AKT1; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER INVASION; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENETIC ENGINEERING; GENETIC RECOMBINATION; IMMUNOPRECIPITATION; LEUKEMIA VIRUS; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; AVIAN LEUKOSIS VIRUS; CELL ADHESION; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; ENZYME ACTIVATION; ENZYME INDUCTION; EPITHELIAL CELLS; FEMALE; MAMMARY GLANDS, ANIMAL; MATRIX METALLOPROTEINASE 2; MICE; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; TRANSDUCTION, GENETIC;

EID: 0035887436     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families
2. Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily
3. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region
4. Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma
5. Specific binding of the Akt-1 protein kinase to phosphatidylinositol 3, 4, 5-trisphosphate without subsequent activation
6. Protein kinase B kinases that mediate phosphatidylinositol 3, 4, 5- trisphosphate-dependent activation of protein kinase B
7. Mechanism of activation of protein kinase B by insulin and IGF-1
8. PI3K: Downstream AKTion blocks apoptosis
9. Role of translocation in the activation and function of protein kinase B
10. Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site
11. PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2
12. The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells
13. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase
14. Protein kinase C-α overexpression stimulates Akt activity and suppresses apoptosis induced by interleukin 3 withdrawal
15. AKT/PKB and other D3 phosphoinositide-regulated kinases: Kinase activation by phosphoinositide-dependent phosphorylation
16. Role of AKTI in 17β-estradiol- and insulin-like growth factor 1 (IGF- 1)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells
17. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas
18. Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase
19. Laminin-a glycoprotein from basement membranes
20. Type IV collagenases in tumor invasion and metastasis
21. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines
22. Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions
23. Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2
24. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3
25. Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type I matrix metalloproteinase activity in high and low invasive melanoma cell lines
26. Overexpression of membrane-type matrix metalloproteinase-I gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice
27. Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) on prostate cancer cell lines
28. Development of mammary preneoplasias in vivo from mouse mammary epithelial cell lines in vitro
29. A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor
30. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias
31. The EV-O-derived cell line DF-1 supports the efficient replication of avian leukosis-sarcoma viruses and vectors
32. The akt kinase: Molecular determinants of oncogenicity
33. Gene transfer into mammalian cells by a Rous sarcoma virus-based retroviral vector with the host range of the amphotropic murine leukemia virus
34. Further evidence that the inhibition of glycogen synthase kinase-3β by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216
35. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis subcellular localization
36. Retroviral gene delivery
37. A system for tissue-specific gene targeting: Transgenic mice susceptible to subgroup A avian leukosis virus-based retroviral vectors
38. Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro
39. Viral Ha-ras mediated mammary tumor progression
40. Differential effects of the simian virus 40 early genes on mammary epithelial cell growth, morphology, and gene expression
41. The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential
42. The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells
43. ets-2 is a target for an akt (Protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice
44. CREB is a regulatory target for the protein kinase Akt/PKB
45. Cell migration through extracellular matrix: Membrane-type metalloproteinases make the way
46. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production
47. Tumor cell invasion through Matrigel is regulated by activated matrix metalloproteinase-2
48. Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion
49. H-ras, but not N-ras, induces an invasive phenotype in human breast epithelial cells: A role for MMP-2 in the H-ras-induced invasive phenotype
50. Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness
51. Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3′-kinase and phospholipase C-dependent mechanism
52. AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells
53. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway
54. Matrix detachment induces caspase-dependent cytochrome c release from mitochondria: Inhibition by PKB/Akt but not Raf signalling
55. Akt/PKB localization and 3′ phosphoinositide generation at sites of epithelial cell-matrix and cell-cell interaction
56. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3
57. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity
58. Adhesion-dependent control of matrix metalloproteinase-2 activation in human capillary endothelial cells
59. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5
60. 3 integrin-mediated cell migration and phosphatidylinositol 3-kinase/AKT pathway activation
61. Human skin fibroblast procollagenase: Mechanisms of activation by organomercurials and trypsin
62. Domain interactious in the gelatinase A. TIMP-2, MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-I matrix inetalloproteinase does not modulate gelatinase A activation
63. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell iuvasion
64. r 72, 000 matrix metalloproteinase at cell surface invadopodia
65. Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor
66. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes
67. Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro
68. Role of MT-MMPs and MMP-2 in pancreatic cancer progression